Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Clinical trial NCT04925752 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04925752
Sponsor: Gilead Sciences
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pre-Exposure Prophylaxis of HIV Infection

Start date: 2021-06-28
Primary completion: 2024-08-21
Enrollment: 3292

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.